<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Type="Primary" Code="L">Life Sciences</BookSubject>
          <BookSubject Type="Secondary" Priority="1" Code="L16008">Cell Biology</BookSubject>
          <BookSubject Type="Secondary" Priority="2" Code="L16010">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor AffiliationIDS="Aff2">
            <EditorName DisplayOrder="Western">
              <GivenName>Neil</GivenName>
              <GivenName>J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
          </Editor>
          <Editor AffiliationIDS="Aff2">
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
          </Editor>
          <Affiliation ID="Aff2">
            <OrgName>University of Bristol Institute of Clinical Neurosciences</OrgName>
            <OrgAddress>
              <Street>Frenchay Hospital</Street>
              <City>Bristol</City>
              <Country>UK</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <BookBackmatter>
        <BookBackmatterInfo>
          <BookBackmatterFirstPage>247</BookBackmatterFirstPage>
          <BookBackmatterLastPage>253</BookBackmatterLastPage>
        </BookBackmatterInfo>
        <BodyBackmatter>
          <Index ID="Ind1">
            <Heading>Index</Heading>
            <IndexDiv>
              <Heading>A</Heading>
              <IndexEntry>
                <PrimaryIE>Adipogenic induction</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Adrenoleukodystrophy (ALD)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Alzheimer’s disease</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Amyotrophic lateral sclerosis (ALS)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>B</Heading>
              <IndexEntry>
                <PrimaryIE>Basal culture media</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Blood–brain barrier (BBB)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Bone marrow-derived cells</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Bone marrow graft</PrimaryIE>
                <SecondaryIE>cryopreservation</SecondaryIE>
                <SecondaryIE>harvest</SecondaryIE>
                <SecondaryIE>quality testing</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Bordetella pertussis</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>5-Bromo-2-deoxyuridine (BrdU) labelling</PrimaryIE>
                <SecondaryIE>chromogen-based immunohistochemistry</SecondaryIE>
                <SecondaryIE>fluorescence-based immunohistochemistry</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>C</Heading>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Caenorhabditis elegans</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>CAG</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Cysteine, adenine and guanine</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Callithrix jacchus</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>CAPIT</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Core assessment protocol for intracerebral transplantation</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>CCA</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Common carotid artery</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Cell identification</PrimaryIE>
                <SecondaryIE>cellular aggregation</SecondaryIE>
                <SecondaryIE>immunostaining</SecondaryIE>
                <SecondaryIE>oligodendrocyte progenitors</SecondaryIE>
                <TertiaryIE>markers</TertiaryIE>
                <TertiaryIE>morphology</TertiaryIE>
                <SecondaryIE>stem cell growth</SecondaryIE>
                <TertiaryIE>markers</TertiaryIE>
                <TertiaryIE>morphology</TertiaryIE>
                <SecondaryIE>yellow spheres/neural progenitors</SecondaryIE>
                <TertiaryIE>markers</TertiaryIE>
                <TertiaryIE>morphology</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Cellular imaging</PrimaryIE>
                <SecondaryIE>extracellular cell labelling</SecondaryIE>
                <TertiaryIE>CD34<Superscript>+</Superscript> cells</TertiaryIE>
                <TertiaryIE>CliniMACS CD34<Superscript>+</Superscript> selection technology (Miltenyi)</TertiaryIE>
                <TertiaryIE>immunomagnetic selection</TertiaryIE>
                <SecondaryIE>intracellular cell labelling</SecondaryIE>
                <TertiaryIE>D-mannose cell coating</TertiaryIE>
                <TertiaryIE>PC-SPIO nanoparticles</TertiaryIE>
                <TertiaryIE>SPIO stabilization</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Central nervous system (CNS)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Chemistry and manufacturing controls (CMC)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Chondrogenic induction</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Chromogen-based BrdU immunohistochemistry</PrimaryIE>
                <SecondaryIE>blocking and antibody steps</SecondaryIE>
                <SecondaryIE>counterstaining</SecondaryIE>
                <SecondaryIE>free-floating sections, slides</SecondaryIE>
                <SecondaryIE>wax and frozen section pre–treatment</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>CMV</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Cytomegalovirus</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Common carotid artery (CCA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Core assessment protocol for intracerebral transplantation (CAPIT)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Cyclophosphamide administration</PrimaryIE>
                <SecondaryIE>anti-emetic prophylaxis</SecondaryIE>
                <SecondaryIE>dosage</SecondaryIE>
                <SecondaryIE>hyperhydration</SecondaryIE>
                <SecondaryIE>risk management</SecondaryIE>
                <SecondaryIE>sodium 2-mercaptoethane sulfonate (Mesna)</SecondaryIE>
                <SecondaryIE>supportive care</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Cysteine, adenine and guanine (CAG)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Cytomegalovirus (CMV)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>D</Heading>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Dania rerio</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Delayed type hypersensitivity (DTH)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Density analyzer program</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Diffusion weighted images (DWI)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Drosophila melanogaster</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Dulbecco’s Modified Eagle Medium (DMEM)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>E</Heading>
              <IndexEntry>
                <PrimaryIE>ECA</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> External carotid artery</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Embryonic stem cell (ESC)</PrimaryIE>
                <SecondaryIE>autologous <Emphasis Type="Italic">vs.</Emphasis> allogeneic cell therapy</SecondaryIE>
                <SecondaryIE>and bone marrow cell fusion</SecondaryIE>
                <SecondaryIE>treatment</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Epidermal growth factor (EGF)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Expanded Disability Status Score (EDSS)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Experimental autoimmune encephalomyelitis (EAE)</PrimaryIE>
                <SecondaryIE>clinical evaluation</SecondaryIE>
                <SecondaryIE>inbred species</SecondaryIE>
                <TertiaryIE>BBB migration</TertiaryIE>
                <TertiaryIE>encephalitogenic and nonencephalitogenic T cells</TertiaryIE>
                <TertiaryIE>MHC molecules</TertiaryIE>
                <TertiaryIE>T cell receptor (TCR)</TertiaryIE>
                <TertiaryIE>Th1 and Th2 cytokines</TertiaryIE>
                <SecondaryIE>induction</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>outbred species</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>External carotid artery (ECA)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>F</Heading>
              <IndexEntry>
                <PrimaryIE>Fast low angle gradient echo (FLASH) sequence</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Fibroblast growth factor (FGF)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Flow cytometric characterization, neural precursor cell</PrimaryIE>
                <SecondaryIE>central nervous system (CNS) cell</SecondaryIE>
                <SecondaryIE>continued and robust neurogenesis</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>antibodies</TertiaryIE>
                <TertiaryIE>commercial media preparation</TertiaryIE>
                <TertiaryIE>dissection instrument</TertiaryIE>
                <TertiaryIE>in-house media preparation</TertiaryIE>
                <TertiaryIE>tissue culture equipment</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>flow cytometric enrichment</TertiaryIE>
                <TertiaryIE>setup</TertiaryIE>
                <TertiaryIE>SVZ tissue dissection</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>FLOWJO analysis software</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Fluorescence-based BrdU immunohistochemistry</PrimaryIE>
                <SecondaryIE>blocking and antibody steps</SecondaryIE>
                <SecondaryIE>wax and frozen section pre-treatment</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Fluorescent activated cell sorting</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>G</Heading>
              <IndexEntry>
                <PrimaryIE>Galactocerebrosidase gene</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Glial cells</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Gliogenesis</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Globoid cell leukodystrophy</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Krabbe’s disease</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Good manufacturing practicable (GMP) process</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Green flourescent protein (GFP)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Growth media preparation</PrimaryIE>
                <SecondaryIE>commercial</SecondaryIE>
                <TertiaryIE>complete NSC media</TertiaryIE>
                <TertiaryIE>culture reagents</TertiaryIE>
                <TertiaryIE>growth factor stock solutions</TertiaryIE>
                <TertiaryIE>hormone supplemented growth media</TertiaryIE>
                <SecondaryIE>in-house</SecondaryIE>
                <TertiaryIE>culture reagents</TertiaryIE>
                <TertiaryIE>stock solutions</TertiaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>H</Heading>
              <IndexEntry>
                <PrimaryIE>Hank’s balanced salt solution (HBSS)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Hanks eagle medium (HEM)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>HD</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Huntington’s disease</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Hematopoietic stem cell (HSC)</PrimaryIE>
                <SecondaryIE>neurological disease</SecondaryIE>
                <SecondaryIE>scale-up and manufacturability</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Hematopoietic stem cell transplantation (HSCT)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Heparin</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Human embryonic stem cells (hESC)</PrimaryIE>
                <SecondaryIE>differentiation</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>recipes</TertiaryIE>
                <TertiaryIE>stock media/solutions</TertiaryIE>
                <TertiaryIE>stock solutions and medium storage</TertiaryIE>
                <TertiaryIE>supplements</TertiaryIE>
                <TertiaryIE>supplies</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>cellular aggregation</TertiaryIE>
                <TertiaryIE>definitive neuroepithelia isolation</TertiaryIE>
                <TertiaryIE>ES aggregates/“embryoid bodies”</TertiaryIE>
                <TertiaryIE>oligodendrocyte progenitors</TertiaryIE>
                <TertiaryIE>stem cell growth</TertiaryIE>
                <TertiaryIE><Emphasis Type="Italic">vs.</Emphasis> primitive and definitive neuroepithelia</TertiaryIE>
                <TertiaryIE>yellow sphere formation</TertiaryIE>
                <SecondaryIE>tumorigenic stroma cells</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Human immunodeficiency virus (HIV)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Human mesenchymal stem cells (hMSC) culture</PrimaryIE>
                <SecondaryIE>bone marrow extraction</SecondaryIE>
                <SecondaryIE>coverslip growth</SecondaryIE>
                <SecondaryIE>immunostaining</SecondaryIE>
                <TertiaryIE>coverslip-grown cultures</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>NSC-like neurosphere suspension</TertiaryIE>
                <SecondaryIE>lab equipment</SecondaryIE>
                <SecondaryIE>long-term storage</SecondaryIE>
                <TertiaryIE>cryopreservation</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>thawing</TertiaryIE>
                <SecondaryIE>neurogenic capacity</SecondaryIE>
                <TertiaryIE>intact fixation</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>neural differentiation</TertiaryIE>
                <TertiaryIE>NSC-like neurosphere generation</TertiaryIE>
                <SecondaryIE>origin confirmation</SecondaryIE>
                <TertiaryIE>adipogenic induction</TertiaryIE>
                <TertiaryIE>chondrogenic induction</TertiaryIE>
                <TertiaryIE>flow cytometry</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>osteogenic induction</TertiaryIE>
                <SecondaryIE>passage</SecondaryIE>
                <SecondaryIE>primary antibodies</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Human Tissue Act (HTA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Huntington’s disease (HD)</PrimaryIE>
                <SecondaryIE>excitotoxic models</SecondaryIE>
                <TertiaryIE>bregma</TertiaryIE>
                <TertiaryIE>sagittal section photomicrograph</TertiaryIE>
                <TertiaryIE>stereotactic apparatus</TertiaryIE>
                <TertiaryIE>striatum</TertiaryIE>
                <SecondaryIE>genetic mouse models</SecondaryIE>
                <TertiaryIE>knock-in models</TertiaryIE>
                <TertiaryIE>transgenic mouse models</TertiaryIE>
                <SecondaryIE>non-mouse models</SecondaryIE>
                <SecondaryIE>stem cells</SecondaryIE>
                <SecondaryIE>transplantation</SecondaryIE>
                <TertiaryIE>donor tissue</TertiaryIE>
                <TertiaryIE>host site</TertiaryIE>
                <TertiaryIE>labelling of cells</TertiaryIE>
                <TertiaryIE>procedure</TertiaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>I</Heading>
              <IndexEntry>
                <PrimaryIE>ICA</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Internal carotid artery</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Immune ablation, multiple sclerosis</PrimaryIE>
                <SecondaryIE>HSC mobilization and collection</SecondaryIE>
                <TertiaryIE>complications and care</TertiaryIE>
                <TertiaryIE>cyclophosphamide administration</TertiaryIE>
                <TertiaryIE>graft processing</TertiaryIE>
                <TertiaryIE>peripheral blood cell collection</TertiaryIE>
                <TertiaryIE>rhG-CSF</TertiaryIE>
                <SecondaryIE>and HSCT</SecondaryIE>
                <TertiaryIE>busulphan administration</TertiaryIE>
                <TertiaryIE>complications and care</TertiaryIE>
                <TertiaryIE>cyclophosphamide administration</TertiaryIE>
                <TertiaryIE>rabbit antithymocyte globulin (rATG)</TertiaryIE>
                <SecondaryIE>patient selection</SecondaryIE>
                <SecondaryIE>postengraftment care</SecondaryIE>
                <SecondaryIE>preparative phase</SecondaryIE>
                <TertiaryIE>bone marrow graft cryopreservation and testing</TertiaryIE>
                <TertiaryIE>bone marrow harvest</TertiaryIE>
                <TertiaryIE>central venous catheter care</TertiaryIE>
                <TertiaryIE>vascular access and postoperative analgesia</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Immunocytochemistry</PrimaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <SecondaryIE>methods</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Immunostaining</PrimaryIE>
                <SecondaryIE>mesenchymal stem cell (MSC)</SecondaryIE>
                <SecondaryIE>oligodendrocyte precursor cell (OPC)</SecondaryIE>
                <SecondaryIE>progenitor and neural stem cells</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Independent review board (IRB)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Injured brain extracts, UCB migration</PrimaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>cell preparation</TertiaryIE>
                <TertiaryIE>migration assay</TertiaryIE>
                <TertiaryIE>tissue extract preparation</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Internal carotid artery (ICA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Internal ribosomal entry site (IRES)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>I.V. transplantation</PrimaryIE>
                <SecondaryIE>infusion</SecondaryIE>
                <TertiaryIE>femoral vein</TertiaryIE>
                <TertiaryIE>jugular vein</TertiaryIE>
                <TertiaryIE>penile vein</TertiaryIE>
                <TertiaryIE>tail vein</TertiaryIE>
                <SecondaryIE>UCB cell preparation</SecondaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>K</Heading>
              <IndexEntry>
                <PrimaryIE>Ki67 anitbody</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Krabbe’s disease</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>L</Heading>
              <IndexEntry>
                <PrimaryIE>LacZ gene encoding</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Leukaemia inhibitory factor (LIF)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Leukodystrophy</PrimaryIE>
                <SecondaryIE>ALD and MLD</SecondaryIE>
                <SecondaryIE>culture, mouse neonates</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>historical evaluation</SecondaryIE>
                <SecondaryIE>oligosphere dissociation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>Pelizaeus–Merzbacher disease (PMD)</SecondaryIE>
                <SecondaryIE>Schwann cells</SecondaryIE>
                <SecondaryIE>transplantation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>M</Heading>
              <IndexEntry>
                <PrimaryIE>Magnetic resonance imaging (MRI), cell tracking</PrimaryIE>
                <SecondaryIE>cell culturing</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>cell labelling</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>cellular imaging</SecondaryIE>
                <TertiaryIE>contrast agents</TertiaryIE>
                <TertiaryIE>extracellular cell labelling</TertiaryIE>
                <TertiaryIE>intracellular cell labelling</TertiaryIE>
                <SecondaryIE>implanted cells</SecondaryIE>
                <TertiaryIE>brain tumors</TertiaryIE>
                <TertiaryIE>injured brain</TertiaryIE>
                <TertiaryIE>iron fluorophore particles</TertiaryIE>
                <TertiaryIE>neurodegenerative disorders</TertiaryIE>
                <TertiaryIE>spinal cord injury (SCI)</TertiaryIE>
                <SecondaryIE>Prussian blue stain</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>in vitro</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>in vivo</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>MBP</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Myelin basic protein</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Medicines and Healthcare products Regulatory Agency (MHRA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Mesenchymal stem cell (MSC)</PrimaryIE>
                <SecondaryIE>human culture</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>immunostaining</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>long-term storage</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>neurogenic capacity</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>origin confirmation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Metachromatic leukodystrophy (MLD)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Middle cerebral artery occlusion (MCAO) model</PrimaryIE>
                <SecondaryIE>induction</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>infarct volume, TTC staining and quantitative analysis</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>intravenous delivery</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>magnetic resonance imaging (MRI)</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>MSC</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Mesenchymal stem cell</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Multicolor flow cytometry</PrimaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <SecondaryIE>methods</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Multi-label fluorescence staining</PrimaryIE>
                <SecondaryIE>blocking and antibody steps</SecondaryIE>
                <SecondaryIE>frozen section pre-treatment</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Multiple sclerosis (MS)</PrimaryIE>
                <SecondaryIE>EAE induction</SecondaryIE>
                <TertiaryIE>inbred species</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <TertiaryIE>outbred species</TertiaryIE>
                <SecondaryIE>HSC mobilization and collection</SecondaryIE>
                <TertiaryIE>complications and care</TertiaryIE>
                <TertiaryIE>cyclophosphamide administration</TertiaryIE>
                <TertiaryIE>graft processing</TertiaryIE>
                <TertiaryIE>peripheral blood cell collection</TertiaryIE>
                <TertiaryIE>rhG-CSF</TertiaryIE>
                <SecondaryIE>and HSCT</SecondaryIE>
                <TertiaryIE>busulphan administration</TertiaryIE>
                <TertiaryIE>complications and care</TertiaryIE>
                <TertiaryIE>cyclophosphamide administration</TertiaryIE>
                <TertiaryIE>rabbit antithymocyte globulin (rATG)</TertiaryIE>
                <SecondaryIE>MOG and PLP</SecondaryIE>
                <SecondaryIE>myelin basic protein (MBP)</SecondaryIE>
                <SecondaryIE>patient selection</SecondaryIE>
                <SecondaryIE>postengraftment care</SecondaryIE>
                <SecondaryIE>preparative phase</SecondaryIE>
                <TertiaryIE>bone marrow graft cryopreservation and testing</TertiaryIE>
                <TertiaryIE>bone marrow harvest</TertiaryIE>
                <TertiaryIE>central venous catheter care</TertiaryIE>
                <TertiaryIE>vascular access and postoperative analgesia</TertiaryIE>
                <SecondaryIE>SCH preparation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>T lymphocytes</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>
                  <Emphasis Type="Italic">Mycobacterium tuberculosis</Emphasis>
                </PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Myelin basic protein (MBP)</PrimaryIE>
                <SecondaryIE>hydrophilic myelin protein</SecondaryIE>
                <SecondaryIE>inbred species</SecondaryIE>
                <SecondaryIE>outbred species</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Myelin oligodendrocyte glycoprotein (MOG)</PrimaryIE>
                <SecondaryIE>humoral and cellular immune response</SecondaryIE>
                <SecondaryIE>immunization</SecondaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>N</Heading>
              <IndexEntry>
                <PrimaryIE>Neural induction medium</PrimaryIE>
                <SecondaryIE>definitive neuroepithelia isolation</SecondaryIE>
                <SecondaryIE>hESC <Emphasis Type="Italic">vs.</Emphasis> primitive and definitive neuroepithelia</SecondaryIE>
                <SecondaryIE>materials, hESC</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neural precursor cell culture, flow cytometric characterization</PrimaryIE>
                <SecondaryIE>central nervous system (CNS) cell</SecondaryIE>
                <SecondaryIE>continued and robust neurogenesis</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>antibodies</TertiaryIE>
                <TertiaryIE>commercial media preparation</TertiaryIE>
                <TertiaryIE>dissection instrument</TertiaryIE>
                <TertiaryIE>in-house media preparation</TertiaryIE>
                <TertiaryIE>tissue culture equipment</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>flow cytometric enrichment</TertiaryIE>
                <TertiaryIE>setup</TertiaryIE>
                <TertiaryIE>SVZ tissue dissection</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neural progenitor cells (NPC)</PrimaryIE>
                <SecondaryIE>brain tisssue preparation</SecondaryIE>
                <TertiaryIE>fixation</TertiaryIE>
                <TertiaryIE>frozen brain processing and sectioning</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>paraffin wax processing and sectioning</TertiaryIE>
                <SecondaryIE>5-bromo-2-deoxyuridine (BrdU) labelling</SecondaryIE>
                <TertiaryIE>chromogen-based immunohistochemistry</TertiaryIE>
                <TertiaryIE>fluorescence-based immunohistochemistry</TertiaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <SecondaryIE>common antibodies</SecondaryIE>
                <SecondaryIE>detection</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>recipes</TertiaryIE>
                <TertiaryIE>supplies and solutions</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>growth and feeding spheres</TertiaryIE>
                <TertiaryIE>isolation and plating</TertiaryIE>
                <TertiaryIE>neurosphere plating</TertiaryIE>
                <TertiaryIE>transplantation</TertiaryIE>
                <SecondaryIE>multi-label fluorescence staining</SecondaryIE>
                <SecondaryIE>sub-granular zone (SGZ)</SecondaryIE>
                <SecondaryIE>sub-ventricular zone (SVG)</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neural stem cells (NSC)</PrimaryIE>
                <SecondaryIE>autologous <Emphasis Type="Italic">vs.</Emphasis> allogeneic cell therapy</SecondaryIE>
                <SecondaryIE>cell number determination</SecondaryIE>
                <SecondaryIE>clinical end point and patient recruitment criteria</SecondaryIE>
                <SecondaryIE>differentiation methods</SecondaryIE>
                <SecondaryIE>good manufacturing practicable (GMP) process</SecondaryIE>
                <SecondaryIE>mode of action assessment</SecondaryIE>
                <SecondaryIE>neurosphere</SecondaryIE>
                <TertiaryIE>generation</TertiaryIE>
                <TertiaryIE>intact fixation</TertiaryIE>
                <TertiaryIE>suspension</TertiaryIE>
                <SecondaryIE>scale up and manufacturability</SecondaryIE>
                <TertiaryIE>cell manufacturing protocols</TertiaryIE>
                <TertiaryIE>hematopoietic stem cells (HSC)</TertiaryIE>
                <TertiaryIE>human embryonic stem cells (hESC) differentiation</TertiaryIE>
                <TertiaryIE>human <Emphasis Type="Italic">vs.</Emphasis> rodent stem cells</TertiaryIE>
                <TertiaryIE>stem cell-based transplant therapy</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neurodegenerative diseases</PrimaryIE>
                <SecondaryIE>CAPIT-HD and CAPIT-PD protocols</SecondaryIE>
                <SecondaryIE>clinical trials</SecondaryIE>
                <TertiaryIE>bone marrow-derived stromal cells</TertiaryIE>
                <TertiaryIE>cell preparation</TertiaryIE>
                <TertiaryIE>cell replacement approach</TertiaryIE>
                <TertiaryIE>human foetal mesencephalic tissue</TertiaryIE>
                <TertiaryIE>PD and HD</TertiaryIE>
                <TertiaryIE>xenotransplantation</TertiaryIE>
                <SecondaryIE>European Union (EU) directives</SecondaryIE>
                <TertiaryIE>good clinical practice (GCP)</TertiaryIE>
                <TertiaryIE>human tissue and cells</TertiaryIE>
                <SecondaryIE>Helsinki and GCP declaration</SecondaryIE>
                <SecondaryIE>independent review board (IRB)</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>6-hydroxydopamine rodent model</TertiaryIE>
                <TertiaryIE>striatal excitotoxic lesion</TertiaryIE>
                <TertiaryIE>transplantation</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>excitotoxic models</TertiaryIE>
                <TertiaryIE>genetic mouse models</TertiaryIE>
                <TertiaryIE>6-hydroxydopamine rodent model</TertiaryIE>
                <TertiaryIE>non-mouse models</TertiaryIE>
                <TertiaryIE>α-synuclein transgenic mice</TertiaryIE>
                <TertiaryIE>transplantation</TertiaryIE>
                <SecondaryIE>neurological disease</SecondaryIE>
                <SecondaryIE>quality control</SecondaryIE>
                <SecondaryIE>stem and precursor cells</SecondaryIE>
                <TertiaryIE>dopaminergic neurons differentiation</TertiaryIE>
                <TertiaryIE>embryonic stem (ES) cell</TertiaryIE>
                <TertiaryIE>induced pluripotent stem (iPS) cells</TertiaryIE>
                <TertiaryIE>neomycin resistance gene</TertiaryIE>
                <TertiaryIE>tyrosine hydroxylase (TH) positive neurons</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neuroepithelial differentiation method</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neurogenesis</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neurological disease</PrimaryIE>
                <SecondaryIE>accessibility</SecondaryIE>
                <SecondaryIE>bone marrow-derived cells</SecondaryIE>
                <SecondaryIE>cell fusion</SecondaryIE>
                <SecondaryIE>haemopoietic stem cell (HSC)</SecondaryIE>
                <SecondaryIE>neurodegenerative disease</SecondaryIE>
                <TertiaryIE>amyotrophic lateral sclerosis (ALS)</TertiaryIE>
                <TertiaryIE>Huntington’s disease (HD)</TertiaryIE>
                <TertiaryIE>multiple sclerosis</TertiaryIE>
                <TertiaryIE>Parkinson’s disease (PD)</TertiaryIE>
                <TertiaryIE>stroke</TertiaryIE>
                <SecondaryIE>non-canonical stem cell repair</SecondaryIE>
                <SecondaryIE>polyploid cells</SecondaryIE>
                <SecondaryIE>stem cell treatment</SecondaryIE>
                <TertiaryIE>accessibility</TertiaryIE>
                <TertiaryIE>delivery</TertiaryIE>
                <TertiaryIE>safety</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neurosphere assay (NSA)</PrimaryIE>
                <SecondaryIE>EGF-response</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>basal and complete media</TertiaryIE>
                <TertiaryIE>general and dissection equipment</TertiaryIE>
                <TertiaryIE>growth and passaging ingredients</TertiaryIE>
                <TertiaryIE>NS media</TertiaryIE>
                <TertiaryIE>tissue culture equipment</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>cell differentiation</TertiaryIE>
                <TertiaryIE>culture establishment</TertiaryIE>
                <TertiaryIE>culture passaging</TertiaryIE>
                <TertiaryIE>immunostaining</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Neurosphere culture</PrimaryIE>
                <SecondaryIE>dissociated cell differentiation</SecondaryIE>
                <SecondaryIE>establishment</SecondaryIE>
                <TertiaryIE>dissociation protocol</TertiaryIE>
                <TertiaryIE>periventricular region dissection</TertiaryIE>
                <TertiaryIE>setup</TertiaryIE>
                <SecondaryIE>passaging</SecondaryIE>
                <SecondaryIE>whole cell differentiation</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Nurr1 expression</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>O</Heading>
              <IndexEntry>
                <PrimaryIE>Oligodendrocyte progenitor cells (OPC)</PrimaryIE>
                <SecondaryIE>cell identification</SecondaryIE>
                <TertiaryIE>markers</TertiaryIE>
                <TertiaryIE>morphology</TertiaryIE>
                <SecondaryIE>culture, mouse neonates</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>human embryonic stem cells</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>markers and dilution</SecondaryIE>
                <SecondaryIE>neonatal brain</SecondaryIE>
                <SecondaryIE>neural progenitor cells</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>oligosphere dissociation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>spinal cord white matter</SecondaryIE>
                <SecondaryIE>tissue culture</SecondaryIE>
                <SecondaryIE>young/adult mice brain</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Organotypic hippocampal culture</PrimaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <SecondaryIE>methods</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Osteogenic induction</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>P</Heading>
              <IndexEntry>
                <PrimaryIE>Parkinson’s disease (PD)</PrimaryIE>
                <SecondaryIE>6-hydroxydopamine rodent model</SecondaryIE>
                <TertiaryIE>bilateral lesions</TertiaryIE>
                <TertiaryIE>dopaminergic cells</TertiaryIE>
                <TertiaryIE>striatal dopamine depletion</TertiaryIE>
                <TertiaryIE>unilateral lesions</TertiaryIE>
                <SecondaryIE>stem cells</SecondaryIE>
                <SecondaryIE>α-synuclein transgenic mice</SecondaryIE>
                <SecondaryIE>transplantation</SecondaryIE>
                <TertiaryIE>donor tissue</TertiaryIE>
                <TertiaryIE>host site</TertiaryIE>
                <TertiaryIE>labelling of cells</TertiaryIE>
                <TertiaryIE>procedure</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Parkinson’s therapy</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Pasteur pipette technique</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>PCNA</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Proliferating cell nuclei antibody</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>PC-SPIO</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Polycation-bound superparamagnetic iron oxide</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Pelizaeus-Merzbacher disease (PMD)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Photochemical lesion</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Polycation-bound superparamagnetic iron oxide (PC-SPIO)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Polyploid cells</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Progenitor and neural stem cells</PrimaryIE>
                <SecondaryIE>EGF-response</SecondaryIE>
                <SecondaryIE>materials</SecondaryIE>
                <TertiaryIE>basal and complete media</TertiaryIE>
                <TertiaryIE>general and dissection equipment</TertiaryIE>
                <TertiaryIE>growth and passaging ingredients</TertiaryIE>
                <TertiaryIE>NS media</TertiaryIE>
                <TertiaryIE>tissue culture equipment</TertiaryIE>
                <SecondaryIE>methods</SecondaryIE>
                <TertiaryIE>cell differentiation</TertiaryIE>
                <TertiaryIE>culture establishment</TertiaryIE>
                <TertiaryIE>culture passaging</TertiaryIE>
                <TertiaryIE>immunostaining</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Proliferating cell nuclei antibody (PCNA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Proteolipid protein (PLP)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>R</Heading>
              <IndexEntry>
                <PrimaryIE>Rabbit antithymocyte globulin (rATG)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Recombinant human granulocyte-colony stimulating factor (rhG-CSF)</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>S</Heading>
              <IndexEntry>
                <PrimaryIE>Schwann cells</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Serum-free culture system</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Neurosphere assay</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>SGZ</PrimaryIE>
                <SeeIE><Emphasis Type="Italic">See</Emphasis> Sub-granular zone</SeeIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Smooth muscle actin (SMA)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>SOX10 protein</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Spastic paraplegia type II (SPG II)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Spinal cord homogenate (SCH)</PrimaryIE>
                <SecondaryIE>immunization</SecondaryIE>
                <SecondaryIE>preparation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Spinal cord injury (SCI), MRI tracking</PrimaryIE>
                <SecondaryIE>balloon-induced compression lesion</SecondaryIE>
                <SecondaryIE>olfactory ensheathing glia (OEG) migration</SecondaryIE>
                <SecondaryIE>Prussian blue staining</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Stem and precursor cells</PrimaryIE>
                <SecondaryIE>dopaminergic neurons differentiation</SecondaryIE>
                <SecondaryIE>embryonic stem (ES) cell</SecondaryIE>
                <SecondaryIE>induced pluripotent stem (iPS) cells</SecondaryIE>
                <SecondaryIE>neomycin resistance gene</SecondaryIE>
                <SecondaryIE>Nurr1 expression</SecondaryIE>
                <SecondaryIE>tyrosine hydroxylase (TH) positive neurons</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Stem cell-based transplant therapy</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Stereomicroscope</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Sub-granular zone (SGZ)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Sub-ventricular zone (SVZ) region</PrimaryIE>
                <SecondaryIE>adult brain</SecondaryIE>
                <SecondaryIE>dot plot scatter analysis</SecondaryIE>
                <SecondaryIE>hippocampal formation</SecondaryIE>
                <SecondaryIE>neural precursor cell enrichment</SecondaryIE>
                <SecondaryIE>tissue dissection</SecondaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Superparamagnetic iron oxide (SPIO) nanoparticles</PrimaryIE>
                <SecondaryIE>cell labeling</SecondaryIE>
                <SecondaryIE>MR contrast agents</SecondaryIE>
                <SecondaryIE>resovist agent</SecondaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>T</Heading>
              <IndexEntry>
                <PrimaryIE>Tissue culture</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>2,3,5-Triphenyltetrazolium chloride (TTC)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Trituration 88</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Trypan blue dye exclusion method</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Trypsin-EDTA</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Tumorigenic stroma cells</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>T<Subscript>2</Subscript>-weighted images (T<Subscript>2</Subscript>WI)</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Tyrosine hydroxylase (TH) positive neurons</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>U</Heading>
              <IndexEntry>
                <PrimaryIE>UK stem cell bank</PrimaryIE>
              </IndexEntry>
              <IndexEntry>
                <PrimaryIE>Umbilical cord blood (UCB) cells</PrimaryIE>
                <SecondaryIE>brain homogenates, flow cytometry</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>hematopoietic cells (HPC)</SecondaryIE>
                <SecondaryIE>immunocytochemistry</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>isolation and cryopreservation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>I.V. transplantation</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>local cell delivery, stereotaxtis</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>migration, injured brain extracts</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>multicolor flow cytometry</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
                <SecondaryIE>organotypic hippocampal culture</SecondaryIE>
                <TertiaryIE>materials</TertiaryIE>
                <TertiaryIE>methods</TertiaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>X</Heading>
              <IndexEntry>
                <PrimaryIE>Xenotransplantation</PrimaryIE>
              </IndexEntry>
            </IndexDiv>
            <IndexDiv>
              <Heading>Z</Heading>
              <IndexEntry>
                <PrimaryIE>Zebrafish</PrimaryIE>
                <SeeIE>
                  <Emphasis Type="Italic">See Dania rerio</Emphasis>
                </SeeIE>
              </IndexEntry>
            </IndexDiv>
          </Index>
        </BodyBackmatter>
        <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_BookBackMatter.pdf" OutputMedium="Online" TargetType="OnlinePDF" PDFType="Typeset"/>
      </BookBackmatter>
    </Book>
  </Series>
</Publisher>
